18F-NaF positron emission tomography/computed tomography in voriconazole-induced periostitis

Clin Rheumatol. 2023 Jul;42(7):1987-1989. doi: 10.1007/s10067-023-06547-2. Epub 2023 Feb 22.

Authors

Noha Al Waragli¹, Claude Bachmeyer², Nacera Ouali³, Alicia Moreno Sabater⁴, Khaldoun Kerrou⁵

Affiliations

¹ Department of Internal Medicine, Tenon Hospital (AP-HP), Paris, France.
² Department of Internal Medicine, Tenon Hospital (AP-HP), Paris, France. claude.bachmeyer@aphp.fr.
³ Department of Nephrology, Tenon Hospital (AP-HP), Paris, France.
⁴ Department of Mycology, Saint-Antoine Hospital (AP-HP), Paris, France.
⁵ Nuclear Medicine & PET/CT Center, Tenon Hospital (AP-HP), Paris, France.

PMID: 36811806
DOI: 10.1007/s10067-023-06547-2

No abstract available

Publication types

Editorial

MeSH terms

Antifungal Agents / adverse effects
Humans
Periostitis* / chemically induced
Periostitis* / diagnostic imaging
Positron Emission Tomography Computed Tomography / methods
Positron-Emission Tomography
Voriconazole / adverse effects

Substances

Voriconazole
Antifungal Agents